STOCK TITAN

Chemed (CHE) Stock News

CHE NYSE

Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.

Chemed Corporation reports developments across two wholly owned subsidiaries: VITAS Healthcare, a provider of hospice and palliative end-of-life care, and Roto-Rooter, which provides plumbing, drain cleaning, water restoration and related services to residential and commercial customers.

Company news commonly covers quarterly operating results, VITAS patient revenue, admissions and census measures, Roto-Rooter service demand, franchise territory acquisitions, credit facility updates, share repurchases, new hospice-care locations and investor conference presentations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.1%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
dividends
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
conferences
-
Rhea-AI Summary

Chemed Corporation (NYSE: CHE) reported its first-quarter financial results for 2023, showing a 5.6% increase in revenue to $560 million. GAAP diluted EPS was $3.58, while adjusted diluted EPS slightly rose by 0.6% to $4.82. The VITAS segment generated $310 million in net patient revenue, a 3.8% increase, despite a 10.5% decline in net income and adjusted EBITDA, largely due to Medicare sequestration cuts. Roto-Rooter saw revenue growth of 7.9% to $250 million and a 9.3% increase in net income. Chemed maintained a strong cash position of $58.1 million and reduced its term loan to $21.3 million. Management plans to update 2023 earnings guidance in June.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.9%
Tags
Rhea-AI Summary

Chemed Corporation (NYSE: CHE) will announce its financial results for Q1 2023 on April 26, 2023, after market close. A conference call is scheduled for April 27, 2023, at 10 a.m. ET to discuss the results and provide business updates. Interested parties can join through the investor relations section of Chemed’s website or via teleconference. A replay of the call will be available two hours post-conclusion. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing and drain cleaning service provider.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
conferences earnings

FAQ

What is the current stock price of Chemed (CHE)?

The current stock price of Chemed (CHE) is $436.27 as of June 19, 2026.

What is the market cap of Chemed (CHE)?

The market cap of Chemed (CHE) is approximately 5.8B.